Skip to content

Evaluation of a translated Japanese version of ObsQoR-10

Evaluation of a translated Japanese version of ObsQoR-10 - ObsQoR-10JP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043032
Enrollment
100
Registered
2021-01-16
Start date
2021-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean &amp

Interventions

None listed

Sponsors

Division of Obstetric Anesthesia, Department of Anesthesiology, Saitama Medical Center, Saitama Medical University
Lead Sponsor
Department of Anesthesiology, Stanford University
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: - Japanese-speaking women greater than 18 years of age who have spontaneous vaginal delivery (including repair of vaginal tears and manual removal of placenta) or elective Cesarean Delivery - Nulliparous ie first baby - We will include all women who have singleton births - Greater than 37 weeks gestational age

Exclusion criteria

Exclusion criteria: - Age < 18 years - Women whose infants have died - Mother or baby requiring ICU after delivery. - Patient refusal - Inability to read or understand written Japanese - Failed neuraxial analgesia: elective cesarean delivery - General anesthesia - Intrapartum cesarean - Assisted/operative (i.e. vacuum, forceps) vaginal delivery - Previous live birth

Design outcomes

Primary

MeasureTime frame
ObsQoR-10 Japanese version (24 hours after delivery to Day 7)

Secondary

MeasureTime frame
EQ5D Japanese version (24 hours after delivery) Global Health Status (24 hours after delivery)

Countries

Japan

Contacts

Public ContactYusuke Mazda

Saitama Medical Center, Saitama Medical University Division of Obstetric Anesthesia, Department of Anesthesiology

mazda@saitama-med.ac.jp049-228-3400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026